| scholarly article | Q13442814 |
| P2093 | author name string | Alan D Frankel | |
| Iván D'Orso | |||
| Jocelyn R Grunwell | |||
| Robert L Nakamura | |||
| Chandreyee Das | |||
| P2860 | cites work | A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat. | Q24302596 |
| The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme | Q24646774 | ||
| HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs | Q24797317 | ||
| Differential recruitment of pre-mRNA splicing factors to alternatively spliced transcripts in vivo | Q24814750 | ||
| Tat gets the "green" light on transcription initiation | Q24815711 | ||
| The transcription elongation factor TFIIS is a component of RNA polymerase II preinitiation complexes | Q27939585 | ||
| Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription | Q28131686 | ||
| Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein | Q28247468 | ||
| Interaction of elongation factors TFIIS and elongin A with a human RNA polymerase II holoenzyme capable of promoter-specific initiation and responsive to transcriptional activators | Q28249621 | ||
| Controlling the elongation phase of transcription with P-TEFb | Q28255518 | ||
| Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3' end processing | Q29614768 | ||
| Implications of macromolecular crowding for protein assembly. | Q30326202 | ||
| Screening RNA-binding libraries using Tat-fusion system in mammalian cells | Q30651338 | ||
| Interaction of U2AF65 RS region with pre-mRNA branch point and promotion of base pairing with U2 snRNA [corrected] | Q71468310 | ||
| Imposing specificity by localization: mechanism and evolvability | Q77565684 | ||
| RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo | Q77962891 | ||
| A novel glutamine-RNA interaction identified by screening libraries in mammalian cells | Q32068514 | ||
| Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity | Q33220546 | ||
| Kinetics of p53 binding to promoter sites in vivo | Q33558659 | ||
| A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat | Q33662926 | ||
| The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. | Q33780734 | ||
| Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators | Q33930741 | ||
| A human RNA polymerase II-containing complex associated with factors necessary for spliceosome assembly | Q33956679 | ||
| Recognition of RNA branch point sequences by the KH domain of splicing factor 1 (mammalian branch point binding protein) in a splicing factor complex | Q33969114 | ||
| A conserved mRNA export machinery coupled to pre-mRNA splicing | Q34120025 | ||
| Trans-activation by HIV-1 Tat via a heterologous RNA binding protein | Q34156002 | ||
| Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors | Q34419716 | ||
| High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS. | Q34420162 | ||
| Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions | Q34467420 | ||
| Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program | Q34471112 | ||
| The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein | Q35211232 | ||
| A 10 residue motif at the C-terminus of the RNA pol II CTD is required for transcription, splicing and 3' end processing. | Q35561598 | ||
| Structure and mechanism of the RNA polymerase II transcription machinery | Q35758805 | ||
| RNA polymerase II structure: from core to functional complexes | Q35804643 | ||
| Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm | Q35872597 | ||
| Multiple links between transcription and splicing | Q35895223 | ||
| The multifactorial nature of HIV-1 latency | Q35935335 | ||
| RS domains contact the pre-mRNA throughout spliceosome assembly | Q36064219 | ||
| Transcription Factor and Polymerase Recruitment, Modification, and Movement on dhsp70 In Vivo in the Minutes following Heat Shock | Q36139169 | ||
| Targeting of U2AF65 to sites of active splicing in the nucleus | Q36262035 | ||
| Beyond the sequence: cellular organization of genome function | Q36744492 | ||
| Functional inactivation of genes by dominant negative mutations | Q38178605 | ||
| Newly Initiated RNA encounters a factor involved in splicing immediately upon emerging from within RNA polymerase II. | Q38336471 | ||
| SR proteins function in coupling RNAP II transcription to pre-mRNA splicing. | Q40115980 | ||
| Transdominant negative mutations | Q40929001 | ||
| Inhibition of Tat-mediated transactivation and HIV replication with Tat mutant and repressor domain fusion proteins | Q40995031 | ||
| Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication | Q41081547 | ||
| Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region. | Q41222921 | ||
| RNA polymerase II C-terminal domain required for enhancer-driven transcription | Q41350631 | ||
| NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation | Q42128724 | ||
| Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression | Q44389543 | ||
| Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus | Q45841020 | ||
| HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus | Q45843803 | ||
| Negative effect of the transcriptional activator GAL4 | Q59072863 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9492-9504 | |
| P577 | publication date | 2008-07-30 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Targeting tat inhibitors in the assembly of human immunodeficiency virus type 1 transcription complexes | |
| P478 | volume | 82 |
| Q34992613 | Autophagy restricts HIV-1 infection by selectively degrading Tat in CD4+ T lymphocytes |
| Q39194586 | Can the HIV-1 splicing machinery be targeted for drug discovery? |
| Q36148507 | Impact of Tat Genetic Variation on HIV-1 Disease |
| Q42027880 | RNA-mediated displacement of an inhibitory snRNP complex activates transcription elongation |
| Q38212101 | Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors |
| Q37820252 | Targeting the protein-protein interactions of the HIV lifecycle |
| Q37117705 | Tat acetylation modulates assembly of a viral-host RNA-protein transcription complex |
| Q39272683 | Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA. |
Search more.